CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.

Recruiting now · Not applicable

Conditions studied: Infective Endocarditis

In brief

1\. Infective Endocarditis (IE) is a rare and serious disease with high morbidity and mortality; 2. Streptoccoci of oral origin are the second more frequent microorganisms responsible for IE; 3. Oral Infectious Foci (OIF) are underdetected using the current recommended clinical examination/Orthopantomogram (OPT) approach; 4. Cone Beam Computed Tomography (CBCT) has a better sensitivity and sensibility to detect OIF than OPT; 5. To date, no study has been performed to assess the potential benefit of a clinical examination/CBCT approach on the oral health status in IE patients. Thus, conducting a randomized controlled trial is highly desirable to assess the potential impact of a clinical examination/CBCT approach on the oral health status of patients hospitalized for IE and potentially to reduce IE new episodes.

Key facts

Study ID

NCT06269679

Run by

Nantes University Hospital

People needed

170

Starts

2024-12-18

Expected to finish

2028-07-18

Last updated by the study team

2026-04-06

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients hospitalized or recently hospitalized for definite IE according to the 2015 ESC classification, naive patients for dental examination and imaging, whatever the IE responsible microorganism;
• Patients with a stable clinical state, meaning stabilized IE patients out of the critical phase, compatible with the performance of an OPT and a CBCT;
• Patients whose life expectancy is expected to be longer than 6 months;
• Patients who agree to visit the dental department of the hospital to carry out OIF eradication or at his/her personal dentist;
• Patients over 18 years old;
• Patients affiliated to a Social Security or a health insurance scheme;
• Patients who have given informed consent to participate to the study.

You may not qualify if…

• OPT or CBCT already performed before the inclusion of the patients in the study and available for the investigator during the patient's hospitalization.
• Medical contraindications to perform OPT or CBCT imaging;
• Absence of microbiologic identification of the IE responsible microorganism;
• Pregnant or breastfeeding women;
• Patients unable to give informed consent to participate to the study (under trusteeship, guardianship and legal protection).

Where it is running

• CHU Bordeaux - Site Pellegrin — Bordeaux, France (enrolling)
• CHU Clermont-Ferrand — Clermont-Ferrand, France (enrolling)
• CHU Grenoble — Grenoble, France (enrolling)
• HCL — Lyon, France (enrolling)
• APHM — Marseille, France (enrolling)
• CHRU Nancy — Nancy, France (enrolling)
• CHU Nantes — Nantes, France (enrolling)
• AP-HP - Site Bretonneau — Paris, France (enrolling)
• CHU Toulouse — Toulouse, France (enrolling)
• CHRU Tours — Tours, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.